이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Linical 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Kazuhiro Hatano

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	19yrs
CEO 소유권	23.2%
경영진 평균 재임 기간	17yrs
이사회 평균 재임 기간	15.8yrs

최근 관리 업데이트

Recent updates

There May Be Some Bright Spots In Linical's (TSE:2183) Earnings

May 22

Some Linical Co., Ltd. (TSE:2183) Shareholders Look For Exit As Shares Take 26% Pounding

Mar 08

Linical (TSE:2183) Is Paying Out A Larger Dividend Than Last Year

Feb 26

CEO

Kazuhiro Hatano (59 yo)

19yrs

테뉴어

Mr. Kazuhiro Hatano has been the President, Chief Executive Officer and Director at Linical Co. Ltd. since June 2005 and as its General Manager of Development Division since February 2010 and served as its...

리더십 팀

이름	위치	테뉴어	보상	소유권
Kazuhiro Hatano	President	19yrs	데이터 없음	23.2% ¥ 2.2b
Akihiro Takahashi	Senior MD	17.2yrs	데이터 없음	12.1% ¥ 1.2b
Shiori Yamaguchi	Chief Compliance Officer	17yrs	데이터 없음	0.35% ¥ 34.3m
Keigo Tsujimoto	Executive VP & Executive Director	12.9yrs	데이터 없음	4.53% ¥ 439.3m
Jun Kawai	Executive VP & Director	5yrs	데이터 없음	2.66% ¥ 257.4m
Masaya Miyazaki	MD of Head of Asia & Director	17.2yrs	데이터 없음	2.66% ¥ 257.4m
Isao Sakamoto	Executive Director	17yrs	데이터 없음	3.25% ¥ 315.3m
Jihoon Hwang	President & CEO of Linical Korea	5.4yrs	데이터 없음	데이터 없음

17.0yrs

평균 재임 기간

56yo

평균 연령

경험이 풍부한 관리: 2183 의 관리팀은 노련하고 경험 (평균 재직 기간 17 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Kazuhiro Hatano	President	19yrs	데이터 없음	23.2% ¥ 2.2b
Akihiro Takahashi	Senior MD	17.2yrs	데이터 없음	12.1% ¥ 1.2b
Shiori Yamaguchi	Chief Compliance Officer	15yrs	데이터 없음	0.35% ¥ 34.3m
Keigo Tsujimoto	Executive VP & Executive Director	16.5yrs	데이터 없음	4.53% ¥ 439.3m
Jun Kawai	Executive VP & Director	18.5yrs	데이터 없음	2.66% ¥ 257.4m
Masaya Miyazaki	MD of Head of Asia & Director	18yrs	데이터 없음	2.66% ¥ 257.4m
Isao Sakamoto	Executive Director	17yrs	데이터 없음	3.25% ¥ 315.3m
Kyoichi Shimomura	Independent Outside Director	less than a year	데이터 없음	데이터 없음
Eri Sugiyama	Independent Outside Director	less than a year	데이터 없음	데이터 없음
Yoshiaki Nakashima	Independent Outside Director	less than a year	데이터 없음	데이터 없음
Yuichi Murakami	Independent Outside Director	less than a year	데이터 없음	데이터 없음
Yoshimitsu Ando	Independent Outside Director	less than a year	데이터 없음	데이터 없음

15.8yrs

평균 재임 기간

58yo

평균 연령

경험이 풍부한 이사회: 2183 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 15.8 년).

Linical 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Linical Co., Ltd., Annual General Meeting, Jun 26, 2024

Linical Co., Ltd., Annual General Meeting, Jun 22, 2023

Less than half of directors are independent

Linical Co., Ltd., Annual General Meeting, Jun 23, 2022

No independent directors

Recent updates

There May Be Some Bright Spots In Linical's (TSE:2183) Earnings

Full year 2024 earnings: EPS exceeds analyst expectations

Consensus EPS estimates increase by 96%

Linical Co., Ltd., Annual General Meeting, Jun 26, 2024

Linical Co., Ltd. Provides Forecast of Consolidated Financial Result for the Year Ending March 31, 2025

Consensus EPS estimates have been upgraded.

Linical Co., Ltd. to Report Fiscal Year 2024 Results on May 15, 2024

Upcoming dividend of JP¥15.00 per share

Some Linical Co., Ltd. (TSE:2183) Shareholders Look For Exit As Shares Take 26% Pounding

Linical (TSE:2183) Is Paying Out A Larger Dividend Than Last Year

Third quarter 2024 earnings released: EPS: JP¥3.32 (vs JP¥4.83 in 3Q 2023)

Linical Co., Ltd. to Report Q3, 2024 Results on Feb 14, 2024

Consensus EPS estimates fall by 16%

New minor risk - Profit margin trend

Linical Co., Ltd. to Report Q2, 2024 Results on Nov 14, 2023

New minor risk - Market cap size

Consensus EPS estimates fall by 12%

New minor risk - Share price stability

First quarter 2024 earnings released: EPS: JP¥0.13 (vs JP¥3.37 in 1Q 2023)

Linical Co., Ltd. to Report Q1, 2024 Results on Aug 14, 2023

Now 22% undervalued

Investor sentiment improves as stock rises 17%

Full year 2023 earnings: EPS exceeds analyst expectations

Linical Co., Ltd., Annual General Meeting, Jun 22, 2023

Upcoming dividend of JP¥14.00 per share at 2.0% yield

Third quarter 2023 earnings released: EPS: JP¥4.83 (vs JP¥12.04 in 3Q 2022)

Linical Co., Ltd. Provides Dividend Guidance for the Full Year Ending March 31, 2023

Linical Co., Ltd. to Report Q3, 2023 Results on Feb 14, 2023

Linical Co., Ltd. Provides Earnings Guidance for the Year Ending March 2023

Price target increased to JP¥1,400

Less than half of directors are independent

Linical Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023

Linical Co., Ltd. to Report Q2, 2023 Results on Nov 14, 2022

First quarter 2023 earnings released: EPS: JP¥3.37 (vs JP¥2.97 in 1Q 2022)

Linical Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

Linical Co., Ltd. to Report Q1, 2023 Results on Aug 12, 2022

Consensus EPS estimates increase by 15%

Full year 2022 earnings: EPS exceeds analyst expectations

Linical Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023

Linical Co., Ltd., Annual General Meeting, Jun 23, 2022

No independent directors

Consensus forecasts updated

Investor sentiment improved over the past week

Upcoming dividend of JP¥14.00 per share

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Linical Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2022

Linical Co., Ltd. to Report Q3, 2022 Results on Feb 14, 2022

Second quarter 2022 earnings released: EPS JP¥8.19 (vs JP¥8.24 in 2Q 2021)

First quarter 2022 earnings released: EPS JP¥2.97 (vs JP¥8.81 loss in 1Q 2021)

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS JP¥23.86 (vs JP¥21.34 in FY 2020)

Upcoming dividend of JP¥14.00 per share

Analysts lower EPS estimates to JP¥10.60

Third quarter 2021 earnings released: EPS JP¥7.53 (vs JP¥7.44 in 3Q 2020)

Revenue and earnings miss expectations

Linical Co., Ltd. to Report Q3, 2021 Results on Feb 12, 2021

Investor sentiment improved over the past week

New 90-day low: JP¥690

New 90-day low: JP¥702

Price target lowered to JP¥900

Linical Co., Ltd. to Report Q2, 2021 Results on Nov 13, 2020

Linical Co., Ltd Enters into Service Contract with the Kitasato Institute

CEO

테뉴어

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령